To Continue or Interrupt DOAC Therapy? The Evidence Remains Unclear – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Alexander Xiang et al, adding:
”For patients undergoing minimal bleeding-risk procedures, this systematic review and meta-analysis suggests the answer may not be so straightforward.
In a new RPTH Journal State of the Art review, across 24 studies involving 8,663 patients, continuous DOAC therapy was associated with fewer thrombotic and major bleeding events in the overall analysis.
However, when the authors focused on the highest-quality randomized trials, those apparent benefits disappeared, showing no significant differences in thrombotic events, major bleeding, minor bleeding, complications, or mortality between continuing and interrupting DOAC therapy.
The take-home message?
Current evidence suggests that either strategy appears acceptable for minimal bleeding-risk procedures, but better randomized studies are still needed to define the optimal approach.”
Title: Continuous vs interrupted direct oral anticoagulants for minimal bleeding-risk surgical procedures—a systematic review and meta-analysis
Authors: Alexander Xiang, Shakil Popatia, Sarah Lopes Sadafi, Megha Rao, Asim Shaikh, Mehrad Nowrouzi, Allen Li, Ali Eshaghpour, Mark Crowther

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice